Xueting Yao

Xueting Yao

Co-authors

Following

Followers

Research Focus & Metrics

Explore full metrics on Scilit

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 April 2020 in European Journal of Pharmaceutical Sciences

Journal Article

Translational prediction of first-in-human pharmacokinetics and pharmacodynamics of janagliflozin, a selective SGLT2 inhibitor, using allometric scaling, dedrick and PK/PD modeling methods

LS

XY

YL

Yang Liu

WZ

Wen Zhong

JJ

Ji Jiang

PH

+7

23 April 2019 in Clinical Drug Investigation

Journal Article

Safety, Pharmacokinetics, and Pharmacogenetics of Single-Dose Teriflunomide Sodium and Leflunomide in Healthy Chinese Subjects

XY

YW

Yiwen Wu

JJ

Ji Jiang

PH

DL

XC

1 August 2019 in European Journal of Pharmaceutical Sciences

Journal Article

A population pharmacokinetic study to accelerate early phase clinical development for a novel drug, teriflunomide sodium, to treat systemic lupus erythematosus

XY

YW

Yiwen Wu

JJ

Ji Jiang

XC

Xia Chen

DL

PH

27 June 2018 in Biomedical Chromatography

Journal Article

A high‐performance liquid chromatography–tandem mass spectrometry method for simultaneous determination of imigliptin, its five metabolites and alogliptin in human plasma and urine and its application to a multiple‐dose pharmacokinetic study

YL

LS

Ling Song

XY

YW

Yiwen Wu

HL

Hongzhong Liu

PH

+6

31 May 2024 in Clinical Pharmacokinetics

Journal Article

Development of a Physiologically Based Pharmacokinetic Population Model for Diabetic Patients and its Application to Understand Disease-drug–drug Interactions

YL

Yafen Li

XL

Xiaonan Li

MZ

Miao Zhu

HL

Huan Liu

ZL

Zihan Lei

DL

+1

7 January 2019 in Biomedical Chromatography

Journal Article

Development of a simple HPLC–MS/MS method to simultaneously determine teriflunomide and its metabolite in human plasma and urine: Application to clinical pharmacokinetic study of teriflunomide sodium and leflunomide

XY

YL

LS

Ling Song

JJ

Ji Jiang

FX

Fei Xiao

PH

+1

About Me

Xueting Yao, PhD., Assistant Researcher of Drug Clinical Trial Center, Peking University Third Hospital. She obtained her PhD degree at Peking Union Medical College Hospital, Chinese Academy of Medical Sciences in August 2019. Her technical expertise is in physiologically based pharmacokinetic model technology. Her main research direction is the early clinical study of new drugs for metabolic diseases such as non-alcoholic steatohepatitis and obesity. She has published 14 SCI articles and presided over one youth project of the National Natural Science Foundation of China.

Xueting Yao, PhD., Assistant Researcher of Drug Clinical Trial Center, Peking University Third Hospital. She obtained her PhD degree at Peking Union Medical College Hospital, Chinese Academy of Medical Sciences in August 2019. Her technical expertise is in physiologically based pharmacokinetic model technology. Her main research direction is the early clinical study of new drugs for metabolic diseases such as non-alcoholic steatohepatitis and obesity. She has published 14 SCI articles and presided over one youth project of the National Natural Science Foundation of China.